Mannkind Corp financial data

Symbol
MNKD on Nasdaq
Industry
Pharmaceutical Preparations
Location
1 Casper Street, Danbury, CT
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 391 % +40.9%
Quick Ratio 31.7 % +16.7%
Debt-to-equity -339 % -42.2%
Return On Equity -14.8 % -415%
Return On Assets 6.19 %
Operating Margin 25.4 % +483%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 304M shares
Common Stock, Shares, Outstanding 303M shares +12.2%
Entity Public Float 1.39B USD +28.2%
Common Stock, Value, Issued 3.03M USD +12.2%
Weighted Average Number of Shares Outstanding, Basic 274M shares +2.77%
Weighted Average Number of Shares Outstanding, Diluted 284M shares +6.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 286M USD +43.5%
General and Administrative Expense 43.7M USD +0.4%
Costs and Expenses 213M USD +11.9%
Operating Income (Loss) 72.6M USD +736%
Nonoperating Income (Expense) -42.1M USD -121%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 30.5M USD +185%
Income Tax Expense (Benefit) 2.93M USD +87.7%
Net Income (Loss) Attributable to Parent 27.6M USD +430%
Earnings Per Share, Basic 0.1 USD/shares +200%
Earnings Per Share, Diluted 0.1 USD/shares +200%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46.3M USD -80.6%
Accounts Receivable, after Allowance for Credit Loss, Current 11.8M USD -20.8%
Inventory, Net 27.9M USD -2.31%
Assets, Current 268M USD -28.1%
Property, Plant and Equipment, Net 85.4M USD +1.36%
Operating Lease, Right-of-Use Asset 13.1M USD +180%
Intangible Assets, Net (Excluding Goodwill) 5.27M USD +391%
Goodwill 1.93M USD 0%
Other Assets, Noncurrent 26.8M USD +260%
Assets 394M USD -17.1%
Accounts Payable, Current 6.79M USD -29.1%
Employee-related Liabilities, Current 20.6M USD +5.46%
Accrued Liabilities, Current 40.3M USD -4.15%
Contract with Customer, Liability, Current 12.4M USD +36.6%
Liabilities, Current 81.8M USD -21.4%
Contract with Customer, Liability, Noncurrent 51.2M USD -26.7%
Operating Lease, Liability, Noncurrent 11.6M USD +197%
Liabilities 473M USD -34.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.11M USD
Retained Earnings (Accumulated Deficit) -3.2B USD +0.85%
Stockholders' Equity Attributable to Parent -78.8M USD +68%
Liabilities and Equity 394M USD -17.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 6.7M USD +480%
Net Cash Provided by (Used in) Financing Activities -3.47M USD -401%
Net Cash Provided by (Used in) Investing Activities -48.4M USD -451%
Common Stock, Shares Authorized 800M shares 0%
Common Stock, Shares, Issued 303M shares +12.2%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -45.2M USD -381%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 97.4M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.93M USD +60.3%
Deferred Tax Assets, Valuation Allowance 694M USD -0.55%
Deferred Tax Assets, Gross 698M USD -0.23%
Operating Lease, Liability 14.1M USD +163%
Depreciation 7.3M USD +62.2%
Payments to Acquire Property, Plant, and Equipment 2.41M USD -71%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12.1M USD +605%
Property, Plant and Equipment, Gross 192M USD +3.38%
Operating Lease, Liability, Current 2.42M USD +70.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 480M USD -5.26%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 269M USD 0%
Operating Lease, Payments 2.29M USD +115%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.52M USD +172%
Share-based Payment Arrangement, Expense 21.4M USD +21%
Interest Expense 14.1M USD -9.88%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%